Article

The CAIRP (CAndesartan for In-stent Restenosis Prevention) trial - A multicenter study of AT1-receptor blocker therapy in coronary stenting.
Kraemer, J., Ruf, R.G., Schmidt, S., Axthelm, C., Strasser, R., Janssen, G., Thieme, T., Kusch, A. ORCID: https://orcid.org/0000-0002-6666-7081, Waigand, J., Dietz, R. and Gross, C.M.
Journal of Invasive Cardiology 20 (5): 205-210. May 2008

Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross, C.M., Perrot, A. ORCID: https://orcid.org/0000-0002-8800-342X, Geier, C. ORCID: https://orcid.org/0000-0001-5281-8187, Posch, M.G., Hassfeld, S., Kramer, J., Schmidt, S., Derer, W., Dietz, R. and Oezcelik, C.
Journal of Invasive Cardiology 19 (6): 261-264. 1 June 2007